carbostyril has been researched along with Otitis Externa in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (8.33) | 18.2507 |
2000's | 4 (33.33) | 29.6817 |
2010's | 3 (25.00) | 24.3611 |
2020's | 4 (33.33) | 2.80 |
Authors | Studies |
---|---|
Antonelli, PJ; Dirain, CO | 1 |
Antonelli, PJ; Rhew, K; Tran, PT; Wang, X; Winterstein, AG | 1 |
Dogan, B; Orhan Kubat, G | 1 |
Cullen, M; Heward, E; Hobson, J | 1 |
Bahat-Dinur, A; El-Seid, S; Kaplan, D; Kraus, M; Peled, C; Tzvi-Ran, LR | 1 |
Alrwisan, A; Antonelli, PJ; Wang, X; Winterstein, AG | 1 |
Hellmich, M; Mösges, R; Nematian-Samani, M; Shah-Hosseini, K | 1 |
Brothers, AM; Gibbs, PS; Wooley, RE | 1 |
Boisramé, B; Borell, D; Pheulpin, S; Rougier, S; Woehrlé, F | 1 |
Bensignor, E; Grandemange, E | 1 |
Nuttall, T | 1 |
González Lama, Z; Lupiola Gómez, P; Martín Barrasa, JL; Tejedor Junco, MT | 1 |
1 review(s) available for carbostyril and Otitis Externa
Article | Year |
---|---|
A meta-analysis of the efficacy of quinolone containing otics in comparison to antibiotic-steroid combination drugs in the local treatment of otitis externa.
Topics: Acute Disease; Administration, Topical; Anti-Bacterial Agents; Drug Therapy, Combination; Female; Humans; Male; Otitis Externa; Quinolones; Steroids | 2011 |
1 trial(s) available for carbostyril and Otitis Externa
Article | Year |
---|---|
A comparative study of two antimicrobial/anti-inflammatory formulations in the treatment of canine otitis externa.
Topics: Administration, Topical; Animals; Anti-Infective Agents, Local; Anti-Inflammatory Agents; Clotrimazole; Dexamethasone; Dog Diseases; Dogs; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Male; Microbial Sensitivity Tests; Otitis Externa; Quinolones; Treatment Outcome | 2005 |
10 other study(ies) available for carbostyril and Otitis Externa
Article | Year |
---|---|
Cytotoxicity of Tetracyclines in Human Tympanic Membrane Fibroblasts.
Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Doxycycline; Fibroblasts; Humans; Minocycline; Otitis Externa; Quinolones; Tetracycline; Tympanic Membrane | 2023 |
Appropriateness of Otic Quinolone Use among Privately Insured US Patients.
Topics: Administration, Ophthalmic; Administration, Topical; Adult; Chi-Square Distribution; Child; Cross-Sectional Studies; Female; Follow-Up Studies; Humans; Insurance, Pharmaceutical Services; Male; Otitis Externa; Otitis Media; Outpatients; Patient Safety; Private Sector; Quinolones; Retrospective Studies; Risk Assessment; Treatment Outcome; United States; United States Food and Drug Administration | 2020 |
Identification of pathogens isolated in acute external otitis cases and evaluation of aminoglycoside and quinolone sensitivity.
Topics: Acute Disease; Administration, Topical; Adult; Age Factors; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Drug Resistance, Microbial; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Otitis Externa; Pseudomonas; Quinolones; Retrospective Studies; Seasons | 2021 |
Microbiology and antimicrobial susceptibility of otitis externa: a changing pattern of antimicrobial resistance.
Topics: Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Candida; Candidiasis; Ciprofloxacin; Drug Resistance, Bacterial; Female; Gentamicins; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Otitis Externa; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolones; Staphylococcal Infections; Staphylococcus aureus | 2018 |
Necrotizing Otitis Externa-Analysis of 83 Cases: Clinical Findings and Course of Disease.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cephalosporins; Disease Progression; Female; Hospitalization; Humans; Male; Middle Aged; Otitis Externa; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolones; Retrospective Studies; Tertiary Care Centers; Treatment Outcome | 2019 |
Risk for Tympanic Membrane Perforation After Quinolone Ear Drops for Acute Otitis Externa.
Topics: Adult; Anti-Bacterial Agents; Child; Humans; Ofloxacin; Otitis Externa; Quinolones; Retrospective Studies; Tympanic Membrane; Tympanic Membrane Perforation | 2020 |
Development of resistant bacteria isolated from dogs with otitis externa or urinary tract infections after exposure to enrofloxacin in vitro.
Topics: Animals; Anti-Infective Agents; Dog Diseases; Dogs; Drug Resistance, Bacterial; Enrofloxacin; Enterococcus; Escherichia coli; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Klebsiella; Microbial Sensitivity Tests; Otitis Externa; Proteus mirabilis; Pseudomonas aeruginosa; Quinolones; Staphylococcus; Urinary Tract Infections | 2002 |
Comparison of an antifungal agent with a mixture of antifungal, antibiotic and corticosteroid agents for the treatment of Malassezia species otitis in dogs.
Topics: Administration, Topical; Adrenal Cortex Hormones; Animals; Anti-Bacterial Agents; Antifungal Agents; Chi-Square Distribution; Clotrimazole; Dermatomycoses; Dexamethasone; Dog Diseases; Dogs; Drug Combinations; Female; Fluoroquinolones; Malassezia; Male; Miconazole; Otitis Externa; Quinolones; Treatment Outcome | 2006 |
What is your diagnosis? Mucocutaneous ulceration.
Topics: Administration, Topical; Animals; Anti-Infective Agents; Cephalexin; Cephalosporins; Diagnosis, Differential; Dog Diseases; Dogs; Enrofloxacin; Erythema Multiforme; Fluoroquinolones; Male; Otitis Externa; Quinolones | 1998 |
Antibacterial susceptibility patterns of Pseudomonas strains isolated from chronic canine otitis externa.
Topics: Animals; Anti-Bacterial Agents; Ceftazidime; Chronic Disease; Dog Diseases; Dogs; Drug Resistance, Microbial; Fluoroquinolones; Microbial Sensitivity Tests; Otitis Externa; Pseudomonas; Pseudomonas Infections; Quinolones; Tobramycin | 2000 |